Giiant Pharma is a preclinical-stage biotech company.
Giiant Pharma has raised $500K in total funding. The most recent round was Grant. The last funding was announced in December 2023.
Giiant Pharma's investors include Fonds de solidarité FTQ, Amplitude Venture Capital, Genesys Capital, AQC Capital, Amorchem.
Giiant Pharma is headquartered in Montréal, Canada.
Giiant Pharma is a preclinical-stage biotech company.
Giiant Pharma is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Giiant Pharma — Funding & Investors." VCBacked, December 28, 2023, https://www.vcbacked.co/company/giiant-pharma. Accessed September 30, 2026.
VCBacked. (2023). Giiant Pharma — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/giiant-pharma
{{cite web |title=Giiant Pharma — Funding & Investors |url=https://www.vcbacked.co/company/giiant-pharma |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated